Literature DB >> 30293274

[Guidelines for diagnosis and treatment of β-thalassemia major (2017)].

.   

Abstract

Entities:  

Year:  2018        PMID： 30293274     DOI： 10.3760/cma.j.issn.0578-1310.2018.10.002

Source DB:  PubMed          Journal:  Zhonghua Er Ke Za Zhi        ISSN： 0578-1310


× No keyword cloud information.
  3 in total

Review 1.  Economic Evaluation of Chelation Regimens for β-Thalassemia Major: a Systematic Review.

Authors:  Jialian Li; Yong Lin; Xue Li; Jiayou Zhang
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-07-01       Impact factor: 2.576

2.  Clinical characteristics, drug resistance and death risk factors of Burkholderia cepacia infection in hematopoietic stem cell transplant patients.

Authors:  Yan Jia; Ya Liu; Yi Liu; Kaitai Yang; Yanfeng Liu
Journal:  BMC Infect Dis       Date:  2022-10-06       Impact factor: 3.667

3.  Cost-Utility Analysis of four Chelation Regimens for β-thalassemia Major: a Chinese Perspective.

Authors:  Jialian Li; Peng Wang; Xue Li; Qiaoyu Wang; Jiayou Zhang; Yong Lin
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-05-01       Impact factor: 2.576
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.